Gf Fund Management Co. Ltd. Alnylam Pharmaceuticals, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $5.85 Trillion
- Q4 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 30,462 shares of ALNY stock, worth $13.7 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
30,462
Previous 2,797
989.1%
Holding current value
$13.7 Million
Previous $1.28 Billion
849.73%
% of portfolio
0.21%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding ALNY
# of Institutions
923Shares Held
117MCall Options Held
1.25MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA16.4MShares$7.38 Billion1.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$6.09 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.29 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.22MShares$3.24 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY4.54MShares$2.04 Billion0.14% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $55.3B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...